News
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...
The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.
GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.
Type 2 diabetes is a chronic health condition that affects millions of people in the UK, often developing gradually over time ...
Turmeric : The dried and ground rhizome (the underground stem) of the Curcuma longa plant. It is a bright yellow-orange spice ...
Caffeine appears to do more than perk you up - it actually helps cells cope with stress and energy shortages, according to ...
Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...
Vitamin B12 deficiency can cause a number of strange sensations, like numbness, tingling, and more. “It felt like electricity ...
“Metformin is a widely used, first-line medication for treating type 2 diabetes.It belongs to a class of drugs called biguanides,” says Hans J. Schmidt, M.D., chief of bariatric surgery and ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results